Archive for December, 2009
Chemo Cooking Classes And The Mighty Mistletoe – Chemotherapy Side-Effect Allaying Aids
Since times long past, Mistletoe was the wonderful pretext for covert admirers to grab a kiss with the ones they yearned for. However studies have indicated that mistletoe could not only light up Christmas excitement but also aid in combating bowel cancer that is observed to annually affect above thirty-seven thousand individuals in the United Kingdom alone.
The study found that when the extract of the mistletoe were administered via jab form on a regular basis into the bloodstream of patients, they experienced lesser side-effects that often accompany toxic chemo and radiotherapy and have lengthier survival rates in comparison to those that were not given this injection.
The mistletoe extract was believed to bolster the body’s immune system in combating tumours and hastening the discarding [...]
December 28th, 2009 |
News
Astonishing Findings On MRI And CAT Scan Risks
MRI or magnetic resonance imaging technique that employs magnetic field rather than ionizing radiation for producing in-depth imagery of the inner body parts could prove to be potentially hazardous for those patients that have heart pacemakers.
The quite strong magnetic fields that are produced by the MRI systems could lead to inadequate stimulation of the patient’s heart during the scan process that could pose lethal consequences to them.
Physicians have received specific instructions by the producers of pacemakers and MRI systems about not exposing those with cardiac pacemakers to MRI scanning. MRI could cause harm to the electronic system of the pacemaker and lead to the heart tissue at the point of the pacemaker lead to burn because of the intense temperatures created during the time [...]
December 22nd, 2009 |
News
Accurate Identification Of Skin Cancer Using High-Frequency Ultrasound With Elastography
According to a latest study, high-frequency ultrasound with elastography could assist in differentiating malignant disorders from harmless skin conditions.
Eliot L. Siegel, M.D., the lead author stated that high-frequency ultrasound with elastography had the likelihood of enhancing diagnosis of skin cancer by effectively delineating the size of the lesions and could offer quantifiable segregation amongst an assortment of harmless and cancerous skin lesions.
According to the American Cancer Society an annual skin cancer diagnosis in the United States has surpassed a million cases. Melanoma, being the gravest form of skin cancer that constitutes nearly close to sixty-nine thousand skin cancer cases and nearly twelve thousand fatalities in 2009, in spite of the fact that with early diagnosis it [...]
December 18th, 2009 |
Skin Cancer
Malignant Melanoma Treatment Options
Thin Melanoma Treatment
The sole treatment alternative in case of thin melanoma is:
Entire removal of the mole.
Employing wide local excision for ensuring that there are no remnant melanoma cells.
Subsequent to the complete removal of the mole and the outcomes of the analysis revealing the presence of a melanoma, then wide local excision would be planned. In case adequate clear tissue was extracted during the time of the mole removal, one would not require undergoing a wide local excision procedure.
Wide Local Excision
During the procedure, the marginal healthy-appearing tissue adjoining the site where the melanoma was present is removed for ascertaining no remnant melanoma cells in the location.
The procedure is conducted under the influence of local or at times under general anaesthesia [...]
December 17th, 2009 |
Skin Cancer
Malignant Melanoma
Malignant Melanoma is a form of cancer generally originating in the skin either as a mole or in healthy-appearing skin. Nearly half the cases of all the melanomas begin in normal skin.
With a continual surge in the number of melanoma cases, there are approximately nine thousand individuals in the United Kingdom being detected with melanoma on an annual basis.
Melanoma is prevalent in the female gender, especially those in the younger age bracket. In the United Kingdom, it is the widespread form of cancer inflicting individuals in the ages of fifteen to thirty-four years, however analogous to majority of the cancers; it is more commonly found to affect elderly individuals as the risk of developing cancer is directly proportional to age. Melanoma is atypically diagnosed in kids below fourteen [...]
December 16th, 2009 |
Skin Cancer
Immunotherapy- Sanguinity For Treatment Of Aggressive Neuroblastoma
Those Kids suffering from aggressive cancer would now be able to reap the benefits of a treatment that has been observed to boost their immune systems.
Chemotherapy, the conventional treatment routine is offered to nearly sixty percent of the young children having neuroblastoma and has proven a success among them.
However, the remnant set –that come under the class of ‘high-risk’ are difficult to cure and merely thirty percent of them have a long-standing survival rate.
Lately, researchers at the Cancer Research UK made an announcement about a new-fangled trial employing immunotherapy – a form of treatment that is observed to support the body in hunting down malignant cells and combat the disease.
The UK trial would be recruiting nearly forty kids yearly for over a span of 4 years – [...]
December 15th, 2009 |
News
Crucial Gene Identification Would Aid In Adeptly Steering Acute Lymphoblastic Leukemia Treatment
Oncologists have detected explicit genes named partner genes which combine with another type of gene for driving a pre-dominantly terminal kind of leukemia among children. Researchers anticipate that by more accurate identification of particular partner genes would aid in better forecasting which children could gain from specific treatments.
Oncologists additionally intend to employ this recent know-how for developing novel and more effectual treatments for acute lymphoblastic leukemia, the most stubborn of all the types of leukemia. The oncologists are aiming at targeting treatments to particular genes and other related factors that turn anomalous due to gene fusions.
ALL is the widespread form of all the childhood cancers. Even though there has been a surge of survival rates in kids over [...]
December 14th, 2009 |
Blood Cancer
Detection And Diagnostic Procedures For Brain Cancer
Not all kinds of brain tumors are known to cause symptoms with few like the tumors of the pituitary gland are detected largely subsequent to demise. Symptoms of brain tumor are copious and not specifically occurring due to brain tumors, which mean that they could also be the outcome of several other ailments. The sole means to ascertaining the precise reasons for the symptoms is undergoing diagnostic testing.
The symptoms arise due to the pressure caused by the tumor or infringing on other areas of the body and hampering their normal functioning.
Few of the symptoms occur due to the swelling in the brain because of the tumor or neighbouring inflammation.
The signs of primary and metastatic brain cancers are analogous.
The below stated signs of brain tumor are most prevalent:
Headaches.
Feeling [...]
December 14th, 2009 |
Brain Cancer
Gall Bladder Cancer – Diagnostic Procedures And Treatment
Gall bladder cancer diagnosis & tests
The doctor would conduct a detailed examination of the patient that would involve getting a comprehensive picture of the overall health condition and any past medical conditions. Blood samples would be drawn for checking the general health and the functioning of the liver. Several commonly employed tests for diagnosis of gall bladder cancer are:
Ultrasound Scan
During the test, sound waves are utilised for capturing images of the gall bladder and neighbouring organs. The patient is requested to not consume any solids or carbonated or milky consistency liquids and to solely sip clear fluids for four to six hours prior to the scan. The patient is told to lie down flat with the back against a comfortable surface. A gel is evenly applied over the abdominal [...]
December 11th, 2009 |
Bladder Cancer
Brain Tumor Cells Made Increasingly Receptive To Radiation Therapy
Researchers from the Duke University have deciphered the way in which stem cells present in the malignant brain cancer glioma could most aptly defend against radiation therapy. By employing a drug for blocking a certain signalling pathway in such cancer stem cells, they could annihilate greater numbers of glioma cells with radiation in a lab trial.
The research work endeavoured at building off the previous research that revealed the greater resistance of cancer stem cells to the effects of radiation therapy in comparison to the other cancer cells.
The Duke researchers recognized a well-known signalling pathway known as Notch as the possible cause for the enhanced resistance. Notch additionally operated in healthy stem cells where it is vital for inter cell communication that manages cell proliferation [...]
December 10th, 2009 |
Brain Cancer

